Reuters logo
BRIEF-VIVUS and Alvogen announce marketing agreement for Qsymia in the Republic of Korea
2017年9月5日 / 中午12点28分 / 17 天前

BRIEF-VIVUS and Alvogen announce marketing agreement for Qsymia in the Republic of Korea

Sept 5 (Reuters) - Alvogen Korea Co Ltd

* VIVUS Inc - ‍Alvogen will be solely responsible for obtaining and maintaining regulatory approvals and for all sales and marketing activities in Korea​​

* VIVUS Inc - ‍Alvogen will market Qsymia in Republic Of Korea for treatment of chronic weight management or weight-related conditions​

* VIVUS Inc - ‍VIVUS will receive an upfront payment in addition to future milestone payments​

* VIVUS Inc - ‍VIVUS will receive royalties on Alvogen’s net sales of Qsymia​ Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below